CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

被引：0
|
作者：
Jetani, Hardikkumar
Garcia-Cadenas, Irene
Nerreter, Thomas
Rydzek, Julian
Thomas, Simone
Herr, Wolfgang
Sierra, Jordi
Bonig, Halvard
Einsele, Hermann
Hudecek, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1351
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
    Lee, Hyo Jeong
    Lee, Jungeun
    Jeong, Pyeonghwa
    Choi, Jungil
    Baek, Juhwa
    Ahn, Su Jin
    Moon, Yeongyu
    Heo, Jeong Doo
    Choi, Young Hee
    Chin, Young-Won
    Kim, Yong-Chul
    Han, Sun-Young
    ONCOTARGET, 2018, 9 (01) : 924 - 936
  • [32] TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax
    Anudishi Tyagi
    Appalaraju Jaggupilli
    Stanley Ly
    Bin Yuan
    Fouad El-Dana
    Venkatesh L. Hegde
    Vivek Anand
    Bijender Kumar
    Mamta Puppala
    Zheng Yin
    Stephen T. C. Wong
    Alexis Mollard
    Hariprasad Vankayalapati
    Jason M. Foulks
    Steven L. Warner
    Naval Daver
    Gautam Borthakur
    V. Lokesh Battula
    Leukemia, 2024, 38 : 82 - 95
  • [33] Clinical Pharmacokinetics and FLT3 Phosphorylation of AC220, a Highly Potent and Selective Inhibitor of FLT3
    James, Joyce
    Pratz, Keith
    Stine, Adam
    Apuy, Julius L.
    Insko, Darren E.
    Armstrong, Robert C.
    Zarrinkar, Patrick P.
    Small, Donald
    Wierenga, Wendell
    Levis, Mark J.
    BLOOD, 2008, 112 (11) : 912 - 912
  • [34] Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
    Wachholz, Vanessa
    Mustafa, Al-Hassan M.
    Zeyn, Yanira
    Henninger, Sven J.
    Beyer, Mandy
    Dzulko, Melanie
    Piee-Staffa, Andrea
    Brachetti, Christina
    Haehnel, Patricia S.
    Sellmer, Andreas
    Mahboobi, Siavosh
    Kindler, Thomas
    Brenner, Walburgis
    Nikolova, Teodora
    Kramer, Oliver H.
    ARCHIVES OF TOXICOLOGY, 2022, 96 (01) : 177 - 193
  • [35] Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
    Vanessa Wachholz
    Al-Hassan M. Mustafa
    Yanira Zeyn
    Sven J. Henninger
    Mandy Beyer
    Melanie Dzulko
    Andrea Piée-Staffa
    Christina Brachetti
    Patricia S. Haehnel
    Andreas Sellmer
    Siavosh Mahboobi
    Thomas Kindler
    Walburgis Brenner
    Teodora Nikolova
    Oliver H. Krämer
    Archives of Toxicology, 2022, 96 : 177 - 193
  • [36] AML and FLT3: An Update on FDA-approved or Under Review Kinase Inhibitors Targeting FLT3 Kinase
    El-Deen, Nada Alaa
    Dokla, Eman M. E.
    Jaballah, Maiy Y.
    Abouzid, Khaled A. M.
    Serya, Rabah A. T.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2024, 67 (05): : 529 - 553
  • [37] Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
    Chen, Fangli
    Ishikawa, Yuichi
    Akashi, Akimi
    Naoe, Tomoki
    Kiyoi, Hitoshi
    ONCOTARGET, 2016, 7 (30) : 47018 - 47032
  • [38] A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations
    Yamaura, Takeshi
    Nakatani, Toshiyuki
    Uda, Ken
    Ogura, Hayato
    Shin, Wigyon
    Kurokawa, Naoya
    Saito, Koichi
    Fujikawa, Norie
    Date, Tomomi
    Takasaki, Masaru
    Terada, Daisuke
    Hirai, Atsushi
    Akashi, Akimi
    Chen, Fangli
    Adachi, Yoshiya
    Ishikawa, Yuichi
    Hayakawa, Fumihiko
    Hagiwara, Shinji
    Naoe, Tomoki
    Kiyoi, Hitoshi
    BLOOD, 2018, 131 (04) : 426 - 438
  • [39] Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myleoid leukemic cells
    Choi, Soo-Jeong
    Lee, Jeong-Eun
    Lee, So-Deok
    Choi, Sang-Un
    Han, Sun-Young
    Kim, Yong-Chul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [40] Terminal Differentiation of FLT3/ITD AML Blasts In Patients Treated with the FLT3 Inhibitor AC220
    Levis, Mark J.
    Sexauer, Amy
    Rajkhowa, Trivikram
    Small, Donald
    Borowitz, Michael J.
    BLOOD, 2010, 116 (21) : 288 - 289
12345